Hjem › Tripelnegativ brystkreft › Florida › Orlando
Kliniske studier for Tripelnegativ brystkreft i Orlando, FL
12 studier for Tripelnegativ brystkreft søker deltakere på steder i og rundt Orlando (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruttererFase 1/2
- Advent Health, Orlando
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekruttererFase 1
- AdventHealth Cancer Institute, Orlando
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
RekruttererFase 3
- Orlando Health Cancer Institute ( Site 0012), Orlando
- AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0007), Altamonte Springs · 9 mi unna
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
RekruttererFase 3
- Orlando Health Cancer Institute ( Site 0030), Orlando
- AdventHealth Altamonte Springs ( Site 0125), Altamonte Springs · 9 mi unna
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
RekruttererFase 3
- AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0044), Altamonte Springs · 9 mi unna
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruttererFase 1
- Sara Cannon Research Institute Lake Nona, Orlando
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
RekruttererFase 1
- Advent Health Medical Group Radiation Oncology at Central Florida, Orlando
SMP-3124LP in Adults With Advanced Solid Tumors
RekruttererFase 1/2
- Advent Health, Celebration · 17 mi unna
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
RekruttererFase 1
- Florida Cancer Specialists - Lake Nona, Orlando
A Study of LY4175408 in Participants With Advanced Cancer
RekruttererFase 1
- Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
Study of XB010 in Subjects With Solid Tumors
RekruttererFase 1
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekruttererFase 1
- Dren Investigational Site, Orlando
Tripelnegativ brystkreft-studier i andre byer
- Houston, TX42 studier
- New York City, NY31 studier
- Nashville, TN28 studier
- Los Angeles, CA27 studier
- Boston, MA26 studier
- San Antonio, TX23 studier
- St. Louis, MO21 studier
- Arlington, VA20 studier
- Atlanta, GA20 studier
- Dallas, TX18 studier
- Chicago, IL16 studier
- Columbus, OH16 studier
Andre studier i Orlando
- Ikke-småcellet lungekreft44 studier
- Fedme32 studier
- Metastatisk kreft29 studier
- Overvekt27 studier
- Alzheimers sykdom25 studier
- Type 2-diabetes25 studier
- Kreft (alle typer)24 studier
- Brystkreft23 studier
- Eggstokkreft22 studier
- Ulcerøs kolitt22 studier
- Lungekreft21 studier
- Kolorektal kreft19 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.